Notice of Intent to Publish a Funding Opportunity Announcement for ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites
ID: 353688Type: Forecasted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $2M

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353688
Timeline
    Description

    The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites. This opportunity aims to explore the feasibility of developing Machine Learning (ML) and Artificial Intelligence (AI) tools that can enhance the accuracy and precision of predicting how individuals with pathogenic genetic variants manifest disease. The objective is to collaboratively identify both genomic and non-genomic factors influencing disease development in individuals carrying pathogenic genetic variants within a research consortium. The ML/AI tools will leverage existing multimodal genomic and non-genomic data and will be cross-validated in genomic translational research settings to ensure their robustness and generalizability. The consortium will also address the ethical, legal, and social implications (ELSI) of integrating ML/AI tools into genomic medicine. The funding opportunity is expected to be published in Spring 2024, with an application due date in Summer 2024.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Similar Opportunities
    Notice of Intent to Publish a Funding Opportunity Announcement for Transforming NHGRI�s Diversity Action Plan (R25 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) plans to publish a Funding Opportunity Announcement (FOA) aimed at transforming the National Human Genome Research Institute's (NHGRI) Diversity Action Plan (R25 Clinical Trials Not Allowed) to enhance workforce diversity in genomics. This initiative seeks to support the training, employment, and retention of individuals from underrepresented backgrounds in the biomedical workforce, aligning with NHGRI's strategic objectives to foster diverse scientific teams that drive innovation and creativity. The FOA is expected to be published in Summer 2023, with applications due in Early 2024, and the estimated award date is set for September 9, 2024. For further inquiries, interested parties can contact Dr. Lucia A. Hindorff at hindorffl@mail.nih.gov.
    Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R21 Clinical Trial Optional)" aimed at stimulating innovative research in the integration of genomic information into clinical care, particularly for populations experiencing health disparities. This initiative encourages proposals that address implementation science, barriers to genomic medicine, and the integration of genomic data with health and social determinants, with a focus on enhancing health equity among underrepresented groups. The grant provides funding up to $250,000, with applications open from November 1, 2023, until the close date of February 11, 2025. Interested applicants can find more information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)" aimed at developing informatics tools that enhance the use of a human pangenome reference as part of the Human Genome Reference Program (HGRP). The initiative seeks to fund projects that create broadly applicable tools for various sectors of genomics, including clinical and functional genomics, with a focus on improving analytical capabilities over existing methods. Up to $4 million will be allocated to support approximately six projects over a maximum period of three years, with individual project budgets capped at $400,000 annually. Interested applicants can find more information and submit inquiries via email to grantsinfo@nih.gov, with the application deadline set for March 3, 2025.
    Notice of Intent to Publish a Funding Opportunity Announcement for Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is preparing to publish a funding opportunity announcement for the "Computational Approaches to Curation at Scale for Biomedical Research Assets" grant, which will not allow clinical trials. This initiative aims to enhance access to secure and comprehensive datasets and computational models that can drive significant advancements in biomedical research, focusing on innovative computational methods to improve data curation processes. The anticipated funding amount for this grant is up to $250,000, with the announcement expected in Fall 2024 and the first application deadline set for February 5, 2025. Interested applicants are encouraged to develop collaborative projects in advance of the official announcement.
    Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)" aimed at supporting innovative research in computational genomics, data science, and bioinformatics. This grant seeks to enhance analytical methodologies, develop and refine software tools, and integrate various genomic data types to improve human health outcomes, with a focus on applications that are broadly applicable across diseases and biological systems. Eligible applicants include a diverse range of organizations, particularly those from underrepresented groups in genomic science, and must adhere to strict application guidelines, including the submission of a Data Management and Sharing Plan. The application deadline is January 7, 2025, and interested parties can find more information and submit their applications electronically through Grants.gov or contact the NIH OER Webmaster at grantsinfo@nih.gov for assistance.
    Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)" aimed at stimulating innovation in the implementation and sharing of genomic information in clinical care across diverse populations. This initiative encourages applications for small research projects that explore the integration of genomic data into clinical practice, assess barriers to implementation, and develop innovative data analysis techniques, particularly focusing on underrepresented populations in genomic research. The maximum budget for each application is $50,000 over a two-year period, with a total funding expectation of approximately $150,000 for FY 2024. Interested applicants must submit their proposals by February 12, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) inviting research proposals focused on the Ethical, Legal, and Social Implications (ELSI) of human genetics and genomics. This initiative aims to encourage multidisciplinary research that explores various methods to address emerging ELSI questions, particularly in relation to health disparities and the implications of genomic data sharing. The NIH emphasizes the importance of including diverse perspectives in research, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application, which will be evaluated during the review process. Interested applicants, including higher education institutions and community-based organizations, can submit proposals starting January 19, 2024, with a closing date for applications set for November 18, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Genomic Community Resources (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity (PAR-23-124) aimed at supporting the development of genomic community resources through cooperative agreements. This initiative seeks to enhance genomic research by funding projects that demonstrate broad applicability and significant value, focusing on the creation of genomic informatics tools, biological material collections, and community engagement efforts. The funded projects will play a crucial role in advancing both basic and clinical genomics research, with awards potentially lasting up to five years. Interested applicants, including a diverse range of organizations such as higher education institutions and nonprofits, must submit their applications by January 25, 2026, and can find further details and submission guidelines at NIH Grants. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Investigator-Initiated Research in Genomics and Health Equity (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Investigator-Initiated Research in Genomics and Health Equity" (RFA-HG-23-017), aimed at promoting health equity through innovative genomic research. This initiative encourages applicants to propose research that enhances the understanding and application of genomics across diverse U.S. populations, with a particular focus on engaging underrepresented groups and incorporating a Plan for Enhancing Diverse Perspectives (PEDP). The NIH plans to commit significant funds, with a maximum budget of $500,000 in direct costs per year for projects lasting four to five years, and applications are due by July 8, 2025. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to review the full announcement at NIH Grants.
    Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a Notice of Funding Opportunity (NOFO) titled "Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II" (PAR-24-241), aimed at establishing a Coordinating Center to enhance psychiatric genetic studies in diverse populations. This initiative seeks to address the underrepresentation of genetic data from non-European ancestries in mental health research, promoting data harmonization, joint analyses, and ethical practices while fostering collaboration among various research projects. Eligible applicants include higher education institutions, non-profits, tribal governments, and other organizations, with the application period opening on September 11, 2024, and a maximum award period of five years. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-24-241.html.